Small Business Innovation Research · Small Business Technology Transfer

Mapp Biopharmaceutical, Inc.: SBIR & STTR awards

4 awards worth $2.30M to 1 companies since 2015 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).

Mapp Biopharmaceutical, Inc.'s federal contracts and grants · All SBIR & STTR awards

Clear

Awards by year

YearPhase IPhase IIAmount
202001$999.0K
201810$150.0K
201701$999.9K
201510$149.9K

The latest year fills in over months: agencies report awards to SBIR.gov with a lag.

Latest matching awards

AwardCompanyAgencyPhaseAmountDate
Marburg Virus Prophylactic Medical Countermeasure · topic CBD18A-002Mapp Biopharmaceutical, Inc. · CaliforniaDepartment of Defense · Office for Chemical and Biological DefenseSTTR Phase II$999.0K2020-07-28
Marburg Virus Prophylactic Medical Countermeasure · topic CBD18A-002Mapp Biopharmaceutical, Inc. · CaliforniaDepartment of Defense · Office for Chemical and Biological DefenseSTTR Phase I$150.0K2018-09-27
Ricin Toxin Protective Monoclonal Antibodies with Improved Serum Half-Life · topic A14-044Mapp Biopharmaceutical, Inc. · CaliforniaDepartment of Defense · ArmySBIR Phase II$999.9K2017-06-22
Ricin Toxin Protective Monoclonal Antibodies with Improved Serum Half-Life · topic A14-044Mapp Biopharmaceutical, Inc. · CaliforniaDepartment of Defense · ArmySBIR Phase I$149.9K2014-12-11

Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.